America Great Health (AAGH)
0.001
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
America Great Health Debt to Equity Ratio: -0.3856 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.3856 |
| September 30, 2023 | -0.3939 |
| June 30, 2023 | -0.4108 |
| March 31, 2023 | -0.4147 |
| December 31, 2022 | -0.3261 |
| September 30, 2022 | -0.3243 |
| June 30, 2022 | -0.3199 |
| March 31, 2022 | -0.3843 |
| December 31, 2021 | -0.4315 |
| September 30, 2021 | -0.9954 |
| June 30, 2021 | -1.244 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -1.177 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -0.5162 |
| December 31, 2015 | -0.6845 |
| September 30, 2015 | -0.7799 |
| June 30, 2015 | -0.01 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -1.060 |
| June 30, 2013 | -0.7716 |
| March 31, 2013 | -1.073 |
| December 31, 2012 | -0.8595 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.1636 |
| March 31, 2012 | -0.4679 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.244
Minimum
Jun 2021
--
Maximum
Jun 2019
-0.2964
Average
-0.3243
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.5332 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 6.294 |
| Protalix BioTherapeutics Inc | 0.6856 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.3236M |
| Total Liabilities (Quarterly) | 5.102M |
| Shareholders Equity (Quarterly) | -4.702M |
| Current Ratio | 0.0765 |
| Net Debt Paydown Yield | -0.03% |